[Intravenous immunoglobulins and autoimmune thrombopenic purpura]

To determine the usefulness of intravenous immunoglobulin in the treatment of autoimmune thrombocytopenic purpura (AITP).

IVIg infusion is an important agent in managing AITP because most patients experienced a rapid increased platelet count. Its precise place in the management of these patients is however controversial, particularly on account of its high cost and transient effect. It is indicated in the severe form of the disease or before surgery in corticoresistant patients.

Prospective studied are mandatory to compare the efficacy of IVIg and high dose corticosteroids in this indication.